TMO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Thermo Fisher Scientific Inc (TMO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options sentiment is mixed, and recent analyst ratings and price target changes suggest caution. Additionally, there is no strong positive catalyst or proprietary trading signal to justify immediate entry. Holding off for better clarity on growth drivers or market performance would be prudent.
The technical indicators for TMO are bearish. The MACD is negatively expanding, RSI is neutral at 40.427, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). Key support is at 461.179, and resistance is at 475.206. The stock is trading near its support level, but there is no clear reversal signal.
No significant positive catalysts are present. Wolfe Research sees TMO as a strong sector anchor with a solid acquisition model, and Citi highlighted potential upside from recent acquisitions.
Analyst downgrades and reduced price targets from HSBC, Barclays, and Evercore ISI reflect concerns about near-term organic growth and structural risks. Congress trading data indicates a cautious stance with recent sale activity. Technical indicators are bearish, and there is no recent news to drive momentum.
No financial data is available for analysis due to an error in the provided data.
Analyst ratings are mixed, with recent downgrades and reduced price targets. Piper Sandler initiated coverage with a Neutral rating and a $510 price target, while HSBC downgraded the stock to Hold with a $540 price target. Wolfe Research and others maintain Buy or Outperform ratings but have reduced price targets, citing structural risks and lack of near-term growth momentum.
